116 related articles for article (PubMed ID: 37642536)
1. Sensitive Detection of Tumor Cells Using Protein Nanoparticles with Multiple Displays of DNA Aptamers and Bioluminescent Reporters.
Nishida K; Wang G; Kobatake E; Mie M
ACS Biomater Sci Eng; 2023 Sep; 9(9):5260-5269. PubMed ID: 37642536
[TBL] [Abstract][Full Text] [Related]
2. Construction of DNA-displaying nanoparticles by enzymatic conjugation of DNA and elastin-like polypeptides using a replication initiation protein.
Guo W; Mashimo Y; Kobatake E; Mie M
Nanotechnology; 2020 Apr; 31(25):255102. PubMed ID: 32176872
[TBL] [Abstract][Full Text] [Related]
3. Development of drug-loaded protein nanoparticles displaying enzymatically-conjugated DNA aptamers for cancer cell targeting.
Mie M; Matsumoto R; Mashimo Y; Cass AEG; Kobatake E
Mol Biol Rep; 2019 Feb; 46(1):261-269. PubMed ID: 30421127
[TBL] [Abstract][Full Text] [Related]
4. Design of luciferase-displaying protein nanoparticles for use as highly sensitive immunoassay detection probes.
Ikeda Y; Mashimo Y; Mie M; Kobatake E
Analyst; 2016 Nov; 141(24):6557-6563. PubMed ID: 27840869
[TBL] [Abstract][Full Text] [Related]
5. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
[TBL] [Abstract][Full Text] [Related]
6. Construction of DNA-NanoLuc luciferase conjugates for DNA aptamer-based sandwich assay using Rep protein.
Mie M; Niimi T; Mashimo Y; Kobatake E
Biotechnol Lett; 2019 Mar; 41(3):357-362. PubMed ID: 30603832
[TBL] [Abstract][Full Text] [Related]
7. Dual-aptamer based electrochemical sandwich biosensor for MCF-7 human breast cancer cells using silver nanoparticle labels and a poly(glutamic acid)/MWNT nanocomposite.
Yazdanparast S; Benvidi A; Banaei M; Nikukar H; Tezerjani MD; Azimzadeh M
Mikrochim Acta; 2018 Aug; 185(9):405. PubMed ID: 30094655
[TBL] [Abstract][Full Text] [Related]
8. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.
Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619
[TBL] [Abstract][Full Text] [Related]
9. Targeted imaging of breast cancer cells using two different kinds of aptamers -functionalized nanoparticles.
Mohammadinejad A; Taghdisi SM; Es'haghi Z; Abnous K; Mohajeri SA
Eur J Pharm Sci; 2019 Jun; 134():60-68. PubMed ID: 30970280
[TBL] [Abstract][Full Text] [Related]
10. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
11. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
Esfandyari-Manesh M; Mohammadi A; Atyabi F; Nabavi SM; Ebrahimi SM; Shahmoradi E; Varnamkhasti BS; Ghahremani MH; Dinarvand R
Int J Pharm; 2016 Dec; 515(1-2):607-615. PubMed ID: 27989825
[TBL] [Abstract][Full Text] [Related]
12. Development of an enhanced immunoassay based on protein nanoparticles displaying an IgG-binding domain and luciferase.
Wang G; Mashimo Y; Kobatake E; Mie M
Anal Bioanal Chem; 2022 Mar; 414(6):2079-2088. PubMed ID: 35037082
[TBL] [Abstract][Full Text] [Related]
13. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo.
Yazdian-Robati R; Arab A; Ramezani M; Rafatpanah H; Bahreyni A; Nabavinia MS; Abnous K; Taghdisi SM
Drug Dev Ind Pharm; 2019 Apr; 45(4):603-610. PubMed ID: 30633594
[TBL] [Abstract][Full Text] [Related]
14. Macromolecular assembly of bioluminescent protein nanoparticles for enhanced imaging.
Li E; Brennan CK; Ramirez A; Tucker JA; Butkovich N; Meli VS; Ionkina AA; Nelson EL; Prescher JA; Wang SW
Mater Today Bio; 2022 Dec; 17():100455. PubMed ID: 36304975
[TBL] [Abstract][Full Text] [Related]
15. Selective collection and detection of MCF-7 breast cancer cells using aptamer-functionalized magnetic beads and quantum dots based nano-bio-probes.
Hua X; Zhou Z; Yuan L; Liu S
Anal Chim Acta; 2013 Jul; 788():135-40. PubMed ID: 23845492
[TBL] [Abstract][Full Text] [Related]
16. Dual aptamer-functionalized silica nanoparticles for the highly sensitive detection of breast cancer.
Jo H; Her J; Ban C
Biosens Bioelectron; 2015 Sep; 71():129-136. PubMed ID: 25897882
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
[TBL] [Abstract][Full Text] [Related]
18. A simple and sensitive impedimetric aptasensor for the detection of tumor markers based on gold nanoparticles signal amplification.
Liu X; Qin Y; Deng C; Xiang J; Li Y
Talanta; 2015 Jan; 132():150-4. PubMed ID: 25476292
[TBL] [Abstract][Full Text] [Related]
19. A slow but steady nanoLuc: R162A mutation results in a decreased, but stable, nanoLuc activity.
Ahmed WS; Geethakumari AM; Sultana A; Fatima A; Philip AM; Uddin SMN; Biswas KH
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131864. PubMed ID: 38692549
[TBL] [Abstract][Full Text] [Related]
20. Dual-target recognition sandwich assay based on core-shell magnetic mesoporous silica nanoparticles for sensitive detection of breast cancer cells.
Wang W; Liu S; Li C; Wang Y; Yan C
Talanta; 2018 May; 182():306-313. PubMed ID: 29501157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
